期刊文献+

供体因素对肾移植术后早期霉酚酸及其代谢物药代动力学的影响 被引量:2

Influence of donor physiological condition on pharmacokinetics of mycophenolic acid and its metabolite in the early period after renal transplantation
原文传递
导出
摘要 目的探讨供体因素对肾移植术后早期霉酚酸(MPA)及其代谢物(MPAG)药代动力学的影响。方法纳入42例服用霉酚酸酯(MMF)患者以及23例服用霉酚酸钠肠溶片(EC-MPS)患者及其供体进行研究。用高效液相色谱法检测患者行活体肾移植术后早期患者霉酚酸及其代谢物的血浆药物浓度,霉酚酸酯组采用本实验室前期建立的有限检样法计算AUC_(MPA)及AUC_(MPAG),霉酚酸钠肠溶片组用线性梯形面积法计算AUC_(MPA)及AUC_(MPAG)。分析供体生理条件及肾功能与肾移植受体术后早期体内药物水平的相关性。结果供体年龄与霉酚酸酯组、霉酚酸钠肠溶片组和全体患者术后早期MPAG水平均呈正相关(P<0.05);霉酚酸酯组及全体患者中,高龄供体(>55岁)组患者术后早期MPAG水平显著高于非高龄供体(≤55岁)组的患者(P<0.05)。受体术前的尿素氮水平在霉酚酸酯组和全体患者中与受体术后早期MPAG水平呈正相关(P<0.05)。根据联合用药方案将患者分为他克莫司(FK506)组和环孢素A(Cs A)组,Cs A组患者AUC_(MPAG)显著高于FK506组(P<0.01),FK506组中高龄供体组术后早期AUC_(MPAG)显著高于非高龄供体组(P<0.05),供体术前的尿素氮水平与患者术后早期AUC_(MPAG)呈显著正相关(P<0.05);Cs A组中供体年龄与患者术后早期AUC_(MPAG)呈显著正相关(P<0.05)。结论供体年龄与术前尿素氮水平是肾移植受体术后早期霉酚酸代谢物水平的重要影响因素。 Objective To investigate the influence of the physiological conditions and kidney function of the donors on their recipients' mycophenolic acid( MPA) and mycophenolic acid glucuronide( MPAG) levels in the early period after renal transplantation. Methods Forty-two patients receiving mycophenolate mofetil( MMF) and 23 patients receiving enteric-coated mycophenolate sodium( EC-MPS),as well as their donors were included in this study. For patients who recieving MMF,MPA and MPAG concentrations were detected by HPLC,then AUC_(MPA)and AUC_MPAGwere calculated by the limited sampling strategy( LSS) model established by our lab previously. For the patients receiving EC-MPS,AUC_(MPA)and AUC_MPAGwere calculated by linear trapezoidal rule. Results Spearman test showed significant correlation between recipients' AUC_MPAG and the age of donors in MMF group,EC-MPS group and the total cohort( P〈0. 05). Moreover,AUC_MPAGin the recipients of elder group( 〉55 yearsold) was significantly higher than that in the younger group( ≤55 years old) in both MMF group and the total cohort( P〈0. 05). In addition,AUC_MPAGwas siginificantly associated with the urea levels of donors before renal transplantation in MMF group and the total cohort( P〈0. 05). Patients were divided into tacrolimus( FK506) or cyclosporin A( CsA) group according to their comedication. AUC_MPAGwas significantly higher in CsA group than that in FK506 group( P〈0. 01). AUC_MPAGin the recipients of elder group was significantly higher than that in the younger group( P〈0. 05),and AUC_MPAGwas siginificantly associated with the urea levels of donors in FK506 group( P〈0. 05). In CsA group,significant correlation between AUC_MPAGand the age of donors was showed( P〈0. 05). Conclusion Our data suggested that the age and the urea level of donors might play roles in the recipients' MPAG exposure in the early period after renal transplantation.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2016年第5期402-405,共4页 The Chinese Journal of Clinical Pharmacology
基金 "十二五"国家科技重大专项基金资助项目(2012ZX09506001-004) 国家自然科学基金资助项目(81102515 81320108027) 广东省重点实验室建设基金资助项目(2011A060901014) 广东省重大科技专项基金资助项目(2011A080300001 2012A080202013)
关键词 供体因素 肾移植术后早期 霉酚酸 药代动力学 donor factors early period after renal transplantation mycophenolic acid pharmacokinetics
  • 相关文献

参考文献10

  • 1EL-SHEIKH A A,KOENDERINK J B,WOUTERSE AC, et al. Renal glucuronidation and multidrug resistance protein 2-/ multi- drug resistance protein 4-mediated efflux of mycophenolic acid : in- teraction with cyclosporine and tacrolimus[J]. Transl Res, 2014 , 164(1):46-56.
  • 2BROWN N W, AW M M, MILEI-VERGANI G, et al. Mycophe- nolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients : effect of cyclosporine and ta- crolimus comedication[J]. Ther Drug Monit,2002,24(1):598-606.
  • 3MOHAMMADPUR A H, NAZEMIAN F,ABTAHI B,et al. Influ- ence of renal graft function on mycophenolic acid pharmacokinetics during the early period after kidney transplant[J]. Exp Clin Trans- plant, 2008,6(4):276-281.
  • 4刘岩峰,李军,黄珈雯,傅茜,刘龙山,陈锷,黄民,王长希.肾移植术后配伍他克莫司时血霉酚酸浓度测定的有限检样法研究[J].中华器官移植杂志,2012,33(2):101-104. 被引量:16
  • 5黄珈雯,刘岩峰,李嘉丽,王利,王长希,钟国平,黄民.高效液相色谱法同时测定霉酚酸及其葡糖苷酸的血浆浓度及临床应用[J].中国基层医药,2011,18(13):1729-1731. 被引量:6
  • 6陈国栋,张霄旦,史磊,王小琴,翟洁,陈立中.供体年龄对活体肾移植预后的影响[J].中华肾脏病杂志,2012,28(6):455-459. 被引量:2
  • 7王宣传,许明,朱同玉,戎瑞明,唐群业,孙立安,王国民.60岁以上供肾亲属肾移植临床疗效分析[J].复旦学报(医学版),2010,37(3):336-338. 被引量:6
  • 8李定云,叶启发,明英姿,成柯,赵于军,朱利军,佘兴国,牛英.老龄活体供肾移植55例[J].实用医学杂志,2010,26(1):53-55. 被引量:5
  • 9陈正,潘光辉,廖德怀,等.老年活体亲属供肾移植的安全性分析[J].中华泌尿外科杂志,2008,29(1):21-25.
  • 10XIA Z W, JUN C Y,HAO C,et al. The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients[J]. Eur J Clin Pharmacol,2010,66(7):671-679.

二级参考文献70

  • 1沈杰,焦正,郁韵秋,迟丹怡,张明,施孝金,钟明康.人血浆中麦考酚酸及其葡糖苷酸代谢物HPLC法测定[J].药物分析杂志,2005,25(2):208-211. 被引量:3
  • 2陈立中,陈国栋,王长希,费继光,邱江,邓素雄,李军.尸肾移植1806例效果分析[J].中华泌尿外科杂志,2006,27(3):166-170. 被引量:15
  • 3蒋继贫,曾凡军,陈知水,明长生,张伟杰,刘斌,杜敦峰,何凡,陈忠华.接受老龄亲属活体供肾移植者采用小剂量西罗莫司的近期临床观察[J].中华器官移植杂志,2006,27(7):418-420. 被引量:2
  • 4刘雄友,明英姿,叶少军,黄湘华,叶启发.不同亲属供肾肾移植临床疗效观察[J].实用医学杂志,2007,23(8):1220-1222. 被引量:7
  • 5陈正 潘光辉 廖德怀 等.老年活体亲属供肾移植的安全性分析[J].中华泌尿外科杂志,2008,29:21-25.
  • 6Johnson E M, Remucal M J, Gillingham K J, et al. Complications and risks of living donor nephrectomy [J]. Transplantation, 1997, 64(8) : 1124-1128.
  • 7Moreso F, Seron D, Gil-Verent S, et al. Donor age and delayed graft function as predictor of renal allograft survival in rejection-free patients [J]. Nephrol Dial Transplant, 1999, 14(4) : 930-933.
  • 8Kerr S R, Gillingham K J, Johnson E M, et al. Living donors > 55 years: to use or not to use [J]? Transplantation, 1999, 67(7): 999-1004.
  • 9Strivastava A, Sinha T, Varma P P, et al. Experience with marginal living related kidney donors: are they becoming routine or are they still any doubts [J]. Urology, 2005, 66(5): 971-975.
  • 10Johnson S R, Khwaja K, Pavlakis M, et al. Older living donors provide excellent quality kidneys: a single center experience [J]. Clin Transplant, 2005, 19(5) : 600-606.

共引文献30

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部